Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Akers Biosciences AKR Holding(s) in Company



  Akers Biosciences (AKR) - Holding(s) in Company

RNS Number : 1660O
Akers Biosciences, Inc.
08 October 2012
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES^i
1. Identity of the issuer or the underlying issuer          Akers Biosciences
of existing shares to which voting rights are
attached:  ^ii                                             ISIN: USU009441051
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments which
may result in the acquisition of shares already issued to which
voting rights are attached
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
An event changing the breakdown of voting rights                         x
Other (please specify):
3. Full name of person(s) subject to the                Commerzbank AG
notification obligation:  ^iii
4. Full name of shareholder(s)
 (if different from 3.):^iv
5. Date of the transaction and date on
which the threshold is crossed or                       4 October 2012
reached: ^v
6. Date on which issuer notified:                      5  October 2012
7. Threshold(s) that is/are crossed or                     Below 5%
reached: ^vi, vii

 

8. Notified details:
A: Voting rights attached to shares ^viii, ix
Class/type of Situation previous        Resulting situation after the triggering
shares        to the triggering         transaction
              transaction
if possible   Number        Number      Number    Number of voting   % of  voting
using         of            of          of shares rights             rights ^x
the ISIN CODE Shares        Voting      Direct    Direct    Indirect Direct   Indirect
                            Rights                ^xi       ^xii
USU009441051  8,728,500     8,728,500   8,728,500 8,728,500          3.51%
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial   Expiration     Exercise/            Number of voting   % of voting
instrument          date ^xiii     Conversion Period    rights that may be rights
                                   ^xiv                 acquired if the
                                                        instrument is
                                                        exercised/
                                                        converted.
n/a
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments ^xv, xvi
Resulting situation after the triggering transaction
Type of        Exercise     Expiration Exercise/  Number of voting      % of voting
financial      price        date ^xvii Conversion rights instrument     rights ^xix,
instrument                             period     refers to             xx
                                       ^xviii
                                                                         
                                                                        Nominal Delta
n/a
                                                   
Total (A+B+C)
Number of voting rights                      Percentage of voting rights
8,728,500                                    3.51%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: ^xxi
 

                                                                              
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease
to hold:
12. Date on which proxy holder will cease to hold
voting rights:
13. Additional information:
                                                          Lisa Carter
14. Contact name:
                                                        Compliance Dept
15. Contact telephone number:                            020 7475 5225

 

                     This information is provided by RNS
           The company news service from the London Stock Exchange
 
END
 
 
HOLUGGGAUUPPGUR -0- Oct/08/2012 11:00 GMT
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement